martes, 20 de septiembre de 2022

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial - The Lancet Respiratory Medicine

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario